Related Experiment Video
Updated: Mar 18, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.4K
Peripartum Cardiomyopathy From a Genetic Perspective
Chizuko A Kamiya1, Jun Yoshimatsu, Tomoaki Ikeda
1Department of Perinatology and Gynecology, National Cerebral and Cardiovascular Center.
Summary
Peripartum cardiomyopathy (PPCM) is a rare heart condition in women. Genetic links to dilated cardiomyopathy (DCM) and hypertensive disorders suggest shared causes and potential future therapies.
Area of Science:
- Cardiology
- Genetics
- Obstetrics
Background:
- Peripartum cardiomyopathy (PPCM) is a rare, life-threatening heart condition affecting women during pregnancy or postpartum.
- Potential risk factors include hypertensive disorders (e.g., preeclampsia), advanced maternal age, and African descent, though etiology is unknown.
- PPCM is a diagnosis of exclusion, with heterogeneous pathogenesis.
Purpose of the Study:
- To explore the genetic underpinnings of PPCM.
- To investigate the relationship between PPCM, dilated cardiomyopathy (DCM), and hypertensive disorders.
- To understand how genetic variations can inform PPCM patient stratification and therapy.
Main Methods:
- Review of cohort studies on PPCM risk factors.
- Analysis of genetic research in PPCM patients.
- Examination of basic research using PPCM model mice.
Main Results:
- 15% of PPCM patients have genetic mutations associated with DCM, correlating with lower recovery rates.
- Hypertensive disorders complicate approximately 40% of PPCM cases.
- Genetic predisposition may link hypertensive and cardiac disorders through angiogenic imbalance.
Conclusions:
- Genetic variations offer new insights into PPCM pathogenesis and heterogeneity.
- Shared genetic factors exist between PPCM, DCM, and hypertensive disorders.
- Understanding genetics can guide personalized therapy and risk stratification for PPCM patients.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
627
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
627
01:25Cardiomyopathy I: Introduction and Classification
753
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
753
01:30Cardiomyopathy II: Dilated Cardiomyopathy
725
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
732
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
732
01:29Cardiomyopathy V: Interprofessional Care
584
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
01:29Cardiomyopathy VI: Nursing Management
440
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
440